Early Pregnancy Termination with Mifepristone and Misoprostol in the United States
- 30 April 1998
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 338 (18), 1241-1247
- https://doi.org/10.1056/nejm199804303381801
Abstract
Mifepristone and a prostaglandin have been used successfully to terminate pregnancy in Europe and China. We report the results of a large U.S. study of mifepristone and misoprostol in women with pregnancies of up to nine weeks' duration.Keywords
This publication has 27 references indexed in Scilit:
- The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicentre study—Final resultsContraception, 1997
- Endocrinology: Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortionHuman Reproduction, 1995
- Clinical pharmacology of RU 486—an antiprogestin and antiglucocorticoidContraception, 1993
- Pregnancy: The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostolHuman Reproduction, 1993
- Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid ActionThe New England Journal of Medicine, 1993
- Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin MisoprostolThe New England Journal of Medicine, 1993
- Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue: Study in 16, 369 womenActa Obstetricia et Gynecologica Scandinavica, 1992
- Voluntary Interruption of Pregnancy with Mifepristone (RU 486) and a Prostaglandin AnalogueThe New England Journal of Medicine, 1990
- Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)The New England Journal of Medicine, 1986
- Progesterone receptor blockage: Effect on uterine contractility and early pregnancyContraception, 1985